Endpoints 11 2026 winner Vivodyne’s human tissue factory could change drug testing
Drug development has a lab-to-clinic translation ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
More in Health & Medicine
Why some patients may develop severe intestinal inflammation after CAR-T therapy
Researchers at the Icahn School of Medicine at Mount Sinai have identified biological mechanisms that may contribute to CAR-T cell-associated enterocolitis, a serious inflammatory condition of the…
How private equity is killing public access to hospitals and emergency care
The corporatization of the health care system by private equity has come with significant costs. While private equity’s ownership of hospitals may earn millions for their investors, they have put…
The FDA approved the new mFlusiva flu vaccine, but the CDC isn’t recommending it. Here’s why
The Food and Drug Administration recently approved a new flu vaccine that tested well in older adults. But the federal agency responsible for telling doctors and the general public how to use it has…
How quickly people age during midlife predicted memory lapses 10 years later
Most people occasionally misplace their car keys or forget a dentist's appointment, especially as they get older. When memory lapses occur regularly and interfere with daily life, however, they could…
Endpoints 11 2026 winner K2 Therapeutics looks to marry China’s speed with global expertise
A small drug developer with ...
Biotech's best startups of 2026: Meet this year's Endpoints 11
The Endpoints 11 awards are our chance to tell a story about where biotech is going. In some ways, biotech feels like it has finally emerged from years of uncertainty. The money that fuels the ...